Position in RPRX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$117,684,942
+$33,253,492 QoQ
Shares Held
2,453,303
+12.3% QoQ
Ownership
0.426%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,976,719,496 across 248 Biotechnology names. RPRX ranks #5 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
This page
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in RPRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $117,684,942 | 2,453,303 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $84,431,450 | 2,185,079 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $68,317,882 | 1,936,448 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $63,097,606 | 1,751,252 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $44,046,644 | 1,414,926 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $81,375,978 | 3,189,964 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $66,262,533 | 2,342,260 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $25,836,901 | 979,784 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $17,286,420 | 569,194 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $15,646,268 | 557,005 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $13,440,838 | 495,241 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $26,012,646 | 846,215 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $19,206,293 | 533,064 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $24,030,727 | 608,065 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $19,650,468 | 489,061 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $19,252,635 | 457,960 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $17,859,885 | 458,416 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $17,179,173 | 431,096 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $11,416,840 | 315,906 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $9,997,786 | 243,908 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $7,667,696 | 175,784 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $10,897,233 | 217,727 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $75,809 | 1,802 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||